Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Commentary|Slideshows|April 24, 2024
The Price of the US Health Care Affordability Crisis: High Anxiety, Skipped Care, Failing Health
Author(s)Grace Halsey
To cover a medical bill, more than half of those surveyed would downsize a home, 75% would take on a second job; more than 1/3 had already skipped care due to costs.
Advertisement
Approximately 1 in 3 adults in the US, nearly 100 million Americans, have medical debt, according to White House statement from the end of 2023. A recent survey of 1007 Americans who had a hospital visit or surgical procedure, for themselves or for a dependent, in the past 24 months, revealed the extent to which medical bills - or the fear of them - can impact the approach to getting care. The survey found that for many, the fear of a future unexpected health care expense, will lead them to avoid seeing a doctor, even when a condition is serious, or to skip a prescription refill. Following are the topline findings from the 2024 survey, commissioned by PayZen , a patient health care financing agency, and conducted by CensusWide.
Advertisement
Related to this article
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
New American Society of Hematology guidelines raise ferritin cutoffs to catch iron deficiency sooner, including pregnancy and inflammation, and add TSAT for clearer diagnosis.
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
The FDA accepted Organon’s MIUDELLA supplemental application, but the proposed change, supporting data, and review timeline remain undisclosed.
Axsome has launched the SUMMIT phase 3 clinical trial evaluating AXS-05 to help adults quit smoking, comparing it with bupropion and placebo over 12 weeks.
A new scientific statement calls for a shift in obesity management and treatment to focus on overall health improvements rather than just weight loss alone.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
The Shift From Off-Label Use to On-Label Agitation Therapy
5